MENU

ATYR aTyr Pharma Inc Forecast, Technical & Fundamental Analysis

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions... Show more

ATYR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ATYR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATYR is expected to report earnings to rise 10.27% to -12 cents per share on August 12

aTyr Pharma Inc ATYR Stock Earnings Reports
Q2'26
Est.
$-0.12
Q1'26
Beat
by $0.03
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.09
Q2'25
Missed
by $0.04
The last earnings report on May 15 showed earnings per share of -10 cents, beating the estimate of -13 cents. With 451.57K shares outstanding, the current market capitalization sits at 49.43M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DWOAX19.66N/A
N/A
BNY Mellon Research Growth A
SLPIX147.47N/A
N/A
ProFunds Small Cap Inv
MIQPX7.03N/A
N/A
Morgan Stanley Inst International Eq R6
GVIZX15.05N/A
N/A
GuideStone Funds Value Equity Index Inv
SHSKX74.28N/A
N/A
BlackRock Health Sciences Opps K

ATYR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with AMLX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-6.41%
AMLX - ATYR
39%
Loosely correlated
-3.32%
IDYA - ATYR
39%
Loosely correlated
-0.78%
SLDB - ATYR
39%
Loosely correlated
-6.46%
NTLA - ATYR
38%
Loosely correlated
-7.93%
CRNX - ATYR
37%
Loosely correlated
-0.05%
More
aTyr Pharma (ATYR) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com